Literature DB >> 20121074

Polyamidoamine (PAMAM) dendrimer conjugates of "clickable" agonists of the A3 adenosine receptor and coactivation of the P2Y14 receptor by a tethered nucleotide.

Dilip K Tosh1, Lena S Yoo, Moshe Chinn, Kunlun Hong, S Michael Kilbey, Matthew O Barrett, Ingrid P Fricks, T Kendall Harden, Zhan-Guo Gao, Kenneth A Jacobson.   

Abstract

We previously synthesized a series of potent and selective A(3) adenosine receptor (AR) agonists (North-methanocarba nucleoside 5'-uronamides) containing dialkyne groups on extended adenine C2 substituents. We coupled the distal alkyne of a 2-octadiynyl nucleoside by Cu(I)-catalyzed "click" chemistry to azide-derivatized G4 (fourth-generation) PAMAM dendrimers to form triazoles. A(3)AR activation was preserved in these multivalent conjugates, which bound with apparent K(i) of 0.1-0.3 nM. They were substituted with nucleoside moieties, solely or in combination with water-solubilizing carboxylic acid groups derived from hexynoic acid. A comparison with various amide-linked dendrimers showed that triazole-linked conjugates displayed selectivity and enhanced A(3)AR affinity. We prepared a PAMAM dendrimer containing equiproportioned peripheral azido and amino groups for conjugation of multiple ligands. A bifunctional conjugate activated both A(3) and P2Y(14) receptors (via amide-linked uridine-5'-diphosphoglucuronic acid), with selectivity in comparison to other ARs and P2Y receptors. This is the first example of targeting two different GPCRs with the same dendrimer conjugate, which is intended for activation of heteromeric GPCR aggregates. Synergistic effects of activating multiple GPCRs with a single dendrimer conjugate might be useful in disease treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20121074      PMCID: PMC2845915          DOI: 10.1021/bc900473v

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  41 in total

Review 1.  Designed multiple ligands. An emerging drug discovery paradigm.

Authors:  Richard Morphy; Zoran Rankovic
Journal:  J Med Chem       Date:  2005-10-20       Impact factor: 7.446

2.  Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.

Authors:  Dilip K Tosh; Moshe Chinn; Andrei A Ivanov; Athena M Klutz; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

3.  2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors.

Authors:  K N Klotz; M J Lohse; U Schwabe; G Cristalli; S Vittori; M Grifantini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

4.  Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.

Authors:  D A Tomalia; L A Reyna; S Svenson
Journal:  Biochem Soc Trans       Date:  2007-02       Impact factor: 5.407

5.  Opioid agonist and antagonist bivalent ligands as receptor probes.

Authors:  P S Portoghese; G Ronsisvalle; D L Larson; C B Yim; L M Sayre; A E Takemori
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

6.  Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition.

Authors:  Arijit Das; Yixing Zhou; Andrei A Ivanov; Rhonda L Carter; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-07-02       Impact factor: 4.774

7.  UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation.

Authors:  Zhan-Guo Gao; Yi Ding; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2009-11-05       Impact factor: 5.858

8.  Toward multivalent signaling across G protein-coupled receptors from poly(amidoamine) dendrimers.

Authors:  Yoonkyung Kim; Béatrice Hechler; Athena M Klutz; Christian Gachet; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2008-01-05       Impact factor: 4.774

9.  NMR characterization of fourth-generation PAMAM dendrimers in the presence and absence of palladium dendrimer-encapsulated nanoparticles.

Authors:  M Victoria Gomez; Javier Guerra; Aldrik H Velders; Richard M Crooks
Journal:  J Am Chem Soc       Date:  2009-01-14       Impact factor: 15.419

10.  Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.

Authors:  Stefania Gessi; Stefania Merighi; Katia Varani; Elena Cattabriga; Annalisa Benini; Prisco Mirandola; Edward Leung; Stephen Mac Lennan; Carlo Feo; Stefania Baraldi; Pier Andrea Borea
Journal:  J Cell Physiol       Date:  2007-06       Impact factor: 6.384

View more
  14 in total

Review 1.  Click chemistry with polymers, dendrimers, and hydrogels for drug delivery.

Authors:  Enrique Lallana; Francisco Fernandez-Trillo; Ana Sousa-Herves; Ricardo Riguera; Eduardo Fernandez-Megia
Journal:  Pharm Res       Date:  2012-01-25       Impact factor: 4.200

2.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

3.  Azide-rich peptides via an on-resin diazotransfer reaction.

Authors:  Jeannette E Marine; Xiaoli Liang; Shuang Song; Jonathan G Rudick
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

4.  Synthesis of BODIPY derivatives substituted with various bioconjugatable linker groups: a construction kit for fluorescent labeling of receptor ligands.

Authors:  Fabian Heisig; Sabrina Gollos; Sven J Freudenthal; Ali El-Tayeb; Jamshed Iqbal; Christa E Müller
Journal:  J Fluoresc       Date:  2013-09-20       Impact factor: 2.217

5.  Anti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart.

Authors:  Bella Chanyshev; Asher Shainberg; Ahuva Isak; Alexandra Litinsky; Yelena Chepurko; Dilip K Tosh; Khai Phan; Zhan-Guo Gao; Edith Hochhauser; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2011-12-01       Impact factor: 7.658

6.  Functionalized congeners of P2Y1 receptor antagonists: 2-alkynyl (N)-methanocarba 2'-deoxyadenosine 3',5'-bisphosphate analogues and conjugation to a polyamidoamine (PAMAM) dendrimer carrier.

Authors:  Sonia de Castro; Hiroshi Maruoka; Kunlun Hong; S Michael Kilbey; Stefano Costanzi; Béatrice Hechler; Garth G Brown; Christian Gachet; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

7.  Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an example.

Authors:  Stephanie Federico; Enrico Margiotta; Silvia Paoletta; Sonja Kachler; Karl-Norbert Klotz; Kenneth A Jacobson; Giorgia Pastorin; Stefano Moro; Giampiero Spalluto
Journal:  Medchemcomm       Date:  2019-02-18       Impact factor: 3.597

8.  GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonists.

Authors:  Angela Kecskés; Dilip K Tosh; Qiang Wei; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2011-05-12       Impact factor: 4.774

9.  GPCR ligand-dendrimer (GLiDe) conjugates: future smart drugs?

Authors:  Kenneth A Jacobson
Journal:  Trends Pharmacol Sci       Date:  2010-10-18       Impact factor: 14.819

10.  Molecular simulation study of PAMAM dendrimer composite membranes.

Authors:  Sepideh Amjad-Iranagh; Karim Golzar; Hamid Modarress
Journal:  J Mol Model       Date:  2014-02-11       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.